A single centre clinical study to assess the clinical efficacy and immunological effects of gefitinib and standard chemotherapy in malignant pleural effusion caused by advanced non-small cell lung cancer.

Trial Profile

A single centre clinical study to assess the clinical efficacy and immunological effects of gefitinib and standard chemotherapy in malignant pleural effusion caused by advanced non-small cell lung cancer.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Gefitinib (Primary) ; Carboplatin; Paclitaxel
  • Indications Malignant pleural effusion; Non-small cell lung cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date (31 Oct 2013) added as reported by Chinese Clinical Trial Register record.
    • 10 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top